Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 20
- 0 vs. Q4 2021
- Portfolio value
- $352.5M
- −$60.2M (−14.6%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| OCGNOcugen, Inc. | Common | 7,111 | $23.0K | <0.1% | 00.0% | Unchanged | History |
| OBSVObsEva SA | COM | 87,999 | $133.0K | <0.1% | 00.0% | Unchanged | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 131,036 | $406.0K | 0.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 240,500 | $553.0K | 0.2% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM | 200,000 | $690.0K | 0.2% | 00.0% | Unchanged | History |
| XCURExicure, Inc. | COM | 6,977,000 | $1.37M | 0.4% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,041,131 | $3.08M | 0.9% | 00.0% | Unchanged | History |
| NCNANuCana plc | SPONSORED ADR | 3,333,333 | $3.28M | 0.9% | 00.0% | Unchanged | History |
| Spruce BioE5209E109 | Common | 1,792,518 | $3.57M | 1.0% | 00.0% | Unchanged | – |
| SLNOSoleno Therapeutics Inc | COM NEW | 18,022,602 | $3.96M | 1.1% | +7,720,000+74.9% | Added | History |
| SIENProject Sage Oldco, Inc. | COM | 2,349,827 | $5.19M | 1.5% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 2,073,957 | $6.08M | 1.7% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,457,499 | $12.1M | 3.4% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,822,114 | $18.9M | 5.4% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,435,106 | $19.5M | 5.5% | +231,971+19.3% | Added | History |
| JSPRJasper Therapeutics, Inc. | COM | 5,628,558 | $19.5M | 5.5% | 00.0% | Unchanged | History |
| SRRASierra Oncology, Inc. | COM | 1,314,012 | $42.1M | 11.9% | +437,356+49.9% | Added | History |
| ACETAdicet Bio, Inc. | COM | 2,115,385 | $42.2M | 12.0% | 00.0% | Unchanged | History |
| VERAVera Therapeutics, Inc. | CL A | 2,960,231 | $69.3M | 19.7% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 4,168,718 | $100.5M | 28.5% | 00.0% | Unchanged | History |